Genetic variation, not cell type of origin, underlies the majority of identifiable regulatory differences in iPSCs
CK Burrows, NE Banovich, BJ Pavlovic… - PLoS …, 2016 - journals.plos.org
The advent of induced pluripotent stem cells (iPSCs) revolutionized human genetics by
allowing us to generate pluripotent cells from easily accessible somatic tissues. This …
allowing us to generate pluripotent cells from easily accessible somatic tissues. This …
Genetic background drives transcriptional variation in human induced pluripotent stem cells
F Rouhani, N Kumasaka, MC de Brito, A Bradley… - PLoS …, 2014 - journals.plos.org
Human iPS cells have been generated using a diverse range of tissues from a variety of
donors using different reprogramming vectors. However, these cell lines are heterogeneous …
donors using different reprogramming vectors. However, these cell lines are heterogeneous …
DNA methylation dynamics in human induced pluripotent stem cells over time
K Nishino, M Toyoda, M Yamazaki-Inoue… - PLoS …, 2011 - journals.plos.org
Epigenetic reprogramming is a critical event in the generation of induced pluripotent stem
cells (iPSCs). Here, we determined the DNA methylation profiles of 22 human iPSC lines …
cells (iPSCs). Here, we determined the DNA methylation profiles of 22 human iPSC lines …
Genetic and epigenetic variations in iPSCs: potential causes and implications for application
The ability to reprogram somatic cells to induced pluripotent stem cells (iPSCs) has
revolutionized the field of regenerative medicine. However, recent studies on the genetic …
revolutionized the field of regenerative medicine. However, recent studies on the genetic …
[HTML][HTML] Hotspots of de novo point mutations in induced pluripotent stem cells
M Yoshihara, R Araki, Y Kasama, M Sunayama, M Abe… - Cell reports, 2017 - cell.com
Induced pluripotent stem cells (iPSCs) are generated by direct reprogramming of somatic
cells and hold great promise for novel therapies. However, several studies have reported …
cells and hold great promise for novel therapies. However, several studies have reported …
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives
KL Nazor, G Altun, C Lynch, H Tran, JV Harness… - Cell stem cell, 2012 - cell.com
Human pluripotent stem cells (hPSCs) are potential sources of cells for modeling disease
and development, drug discovery, and regenerative medicine. However, it is important to …
and development, drug discovery, and regenerative medicine. However, it is important to …
Imprinting fidelity in mouse iPSCs depends on sex of donor cell and medium formulation
M Arez, M Eckersley-Maslin, T Klobučar… - Nature …, 2022 - nature.com
Reprogramming of somatic cells into induced Pluripotent Stem Cells (iPSCs) is a major leap
towards personalised approaches to disease modelling and cell-replacement therapies …
towards personalised approaches to disease modelling and cell-replacement therapies …
Impact of regulatory variation across human iPSCs and differentiated cells
Induced pluripotent stem cells (iPSCs) are an essential tool for studying cellular
differentiation and cell types that are otherwise difficult to access. We investigated the use of …
differentiation and cell types that are otherwise difficult to access. We investigated the use of …
Analysis of transcriptional variability in a large human iPSC library reveals genetic and non-genetic determinants of heterogeneity
Variability in induced pluripotent stem cell (iPSC) lines remains a concern for disease
modeling and regenerative medicine. We have used RNA-sequencing analysis and linear …
modeling and regenerative medicine. We have used RNA-sequencing analysis and linear …
Aberrant DNA methylation in human iPSCs associates with MYC-binding motifs in a clone-specific manner independent of genetics
Induced pluripotent stem cells (iPSCs) show variable methylation patterns between lines,
some of which reflect aberrant differences relative to embryonic stem cells (ESCs). To …
some of which reflect aberrant differences relative to embryonic stem cells (ESCs). To …